17 Sept 2026, 08:51
Company Administration—
BB1BLINKLAB LIMITED
Announcement history available from 1 August 2025
Fromto
11 Sept 2026, 14:57
Director Interests—
10 Sept 2026, 19:10
Securities Administration—
10 Sept 2026, 19:07
Securities Administration—
10 Sept 2026, 08:30
Director Interests—
10 Sept 2026, 08:29
Director Interests—
10 Sept 2026, 08:29
Securities Administration—
8 Sept 2026, 09:05
Company Administration—
7 Sept 2026, 17:02
Meetings & Governance—
1 Sept 2026, 08:56
Presentations—
12 Aug 2026, 14:35
Other—
5 Aug 2026, 10:04
Presentations—
5 Aug 2026, 09:15
Company UpdateMS
4 Aug 2026, 16:55
Meetings & Governance—
4 Aug 2026, 16:54
Meetings & Governance—
3 Aug 2026, 09:24
Trading Halt / SuspensionMS
31 July 2026, 14:28
Company Administration—
31 July 2026, 14:26
Financial ResultsMS
27 July 2026, 09:58
Company Administration—
27 July 2026, 09:08
Quarterly ReportsMS
14 July 2026, 16:22
Director Interests—
14 July 2026, 09:25
Company Update—
13 July 2026, 15:03
Securities Administration—
13 July 2026, 14:54
Securities Administration—
13 July 2026, 14:44
Securities Administration—
13 July 2026, 14:35
Securities Administration—
1 July 2026, 16:44
Securities Administration—
26 June 2026, 09:22
Company Update—
25 June 2026, 16:53
Meetings & Governance—
18 June 2026, 09:20
Company Update—
16 June 2026, 09:11
Company Update—
22 May 2026, 11:22
Meetings & Governance—
22 May 2026, 11:20
Meetings & Governance—
19 May 2026, 09:46
Company Update—
14 May 2026, 09:33
Company Administration—
30 Apr 2026, 08:39
Quarterly ReportsMS
23 Apr 2026, 09:46
Securities Administration—
23 Apr 2026, 09:41
Securities Administration—
17 Apr 2026, 09:23
Presentations—
16 Apr 2026, 17:44
Securities Administration—
16 Apr 2026, 09:28
Securities Administration—
16 Apr 2026, 09:27
Capital RaisingMS
14 Apr 2026, 09:00
Trading Halt / SuspensionMS
7 Apr 2026, 12:22
Securities Administration—
26 Mar 2026, 10:51
Securities Administration—
24 Mar 2026, 09:35
Company UpdateMS
23 Mar 2026, 09:48
Company UpdateMS
19 Mar 2026, 09:38
Trading Halt / SuspensionMS
16 Mar 2026, 09:44
Company UpdateMS
13 Mar 2026, 09:21
Company Update—
| Date / Time | Heading | Type | MS | Report Codes | |
|---|---|---|---|---|---|
| 17 Sept 2026, 08:51 | BB1 to Present at NSSpain - Apple Developer Conference | Company Administration | — | 12008 | |
| 11 Sept 2026, 14:57 | Change of Director's Interest Notice x3 | Director Interests | — | 02009 | |
| 10 Sept 2026, 19:10 | Section 708A Notice | Securities Administration | — | 06018 | |
| 10 Sept 2026, 19:07 | Application for quotation of securities - BB1 | Securities Administration | — | 06020 | |
| 10 Sept 2026, 08:30 | Initial Director's Interest Notice | Director Interests | — | 02008 | |
| 10 Sept 2026, 08:29 | Final Director's Interest Notice | Director Interests | — | 02010 | |
| 10 Sept 2026, 08:29 | Notification regarding unquoted securities - BB1 | Securities Administration | — | 06021 | |
| 8 Sept 2026, 09:05 | Former Apple Health Clinical Lead Appointed to the Board | Company Administration | — | 12001 | |
| 7 Sept 2026, 17:02 | Results of AGM | Meetings & Governance | — | 08003 | |
| 1 Sept 2026, 08:56 | Corporate Presentation Update | Presentations | — | 03026 | |
| 12 Aug 2026, 14:35 | Resignation and Appointment of Auditor | Other | — | 12018 | |
| 5 Aug 2026, 10:04 | Investor Webinar - Positive European ADHD Study Results | Presentations | — | 14014 | |
| 5 Aug 2026, 09:15 | European ADHD Study Delivers Positive Results | Company Update | MS | 09014, 11001 | |
| 4 Aug 2026, 16:55 | Letter to Shareholders & Proxy Form | Meetings & Governance | — | 08004, 08006, 16002 | |
| 4 Aug 2026, 16:54 | Notice of Annual General Meeting & Proxy Form | Meetings & Governance | — | 08001, 08004 | |
| 3 Aug 2026, 09:24 | Trading Halt | Trading Halt / Suspension | MS | 09007 | |
| 31 July 2026, 14:28 | Appendix 4G & Corporate Governance Statement | Company Administration | — | 03024, 03025 | |
| 31 July 2026, 14:26 | 2026 Annual Report & Appendix 4E | Financial Results | MS | 03001, 03002, 03003, 03011, 03012, 03013, 03020 | |
| 27 July 2026, 09:58 | BlinkLab to Present at TechKnow Invest Roadshow | Company Administration | — | 12008 | |
| 27 July 2026, 09:08 | Quarterly Activities/Appendix 4C Cash Flow Report | Quarterly Reports | MS | 19004, 19009 | |
| 14 July 2026, 16:22 | Change of Director's Interest Notice x4 | Director Interests | — | 02009 | |
| 14 July 2026, 09:25 | Company Update on Clinical Development Programs | Company Update | — | 11001 | |
| 13 July 2026, 15:03 | Section 708A Notice | Securities Administration | — | 06018 | |
| 13 July 2026, 14:54 | Notification regarding unquoted securities - BB1 | Securities Administration | — | 06021 | |
| 13 July 2026, 14:44 | Application for quotation of securities - BB1 | Securities Administration | — | 06020 | |
| 13 July 2026, 14:35 | Application for quotation of securities - BB1 | Securities Administration | — | 06020 | |
| 1 July 2026, 16:44 | Notification regarding unquoted securities - BB1 | Securities Administration | — | 06021 | |
| 26 June 2026, 09:22 | European ADHD Study Update | Company Update | — | 11001 | |
| 25 June 2026, 16:53 | Results of General Meeting | Meetings & Governance | — | 08003 | |
| 18 June 2026, 09:20 | BB1 Granted Foundational U.S. Patent | Company Update | — | 11001 | |
| 16 June 2026, 09:11 | BB1 Partners with ESPOCH on Large-Scale Multicenter Program | Company Update | — | 11001 | |
| 22 May 2026, 11:22 | Letter to Shareholders & Proxy Form | Meetings & Governance | — | 08004, 16002 | |
| 22 May 2026, 11:20 | Notice of General Meeting & Proxy Form | Meetings & Governance | — | 08004, 08007 | |
| 19 May 2026, 09:46 | Therapy Evaluation for Neurodevelopmental Conditions | Company Update | — | 11001 | |
| 14 May 2026, 09:33 | BB1 to present at Stocks in the Vines Investor Access Day | Company Administration | — | 12008 | |
| 30 Apr 2026, 08:39 | Quarterly Activities/Appendix 4C Cash Flow Report | Quarterly Reports | MS | 19003, 19008 | |
| 23 Apr 2026, 09:46 | Section 708A Notice | Securities Administration | — | 06018 | |
| 23 Apr 2026, 09:41 | Application for quotation of securities - BB1 | Securities Administration | — | 06020 | |
| 17 Apr 2026, 09:23 | BlinkLab Invited to Present at Ignite Investment Summits | Presentations | — | 03026 | |
| 16 Apr 2026, 17:44 | Update - Proposed issue of securities - BB1 | Securities Administration | — | 06013 | |
| 16 Apr 2026, 09:28 | Proposed issue of securities - BB1 | Securities Administration | — | 06013 | |
| 16 Apr 2026, 09:27 | BlinkLab Secures A$17.5M to Launch Autism Diagnostic Aid | Capital Raising | MS | 06003, 09014 | |
| 14 Apr 2026, 09:00 | Trading Halt | Trading Halt / Suspension | MS | 09007 | |
| 7 Apr 2026, 12:22 | Application for quotation of securities - BB1 | Securities Administration | — | 06020 | |
| 26 Mar 2026, 10:51 | Notice of Release of Escrowed Securities | Securities Administration | — | 06009 | |
| 24 Mar 2026, 09:35 | Validation Program Commences-FDA 510(k) - First Participant | Company Update | MS | 11001 | |
| 23 Mar 2026, 09:48 | Morocco's Nationwide Government-Funded Autism Screening | Company Update | MS | 09014, 11001 | |
| 19 Mar 2026, 09:38 | Trading Halt | Trading Halt / Suspension | MS | 09007 | |
| 16 Mar 2026, 09:44 | Clinical Trial Network for Pivotal FDA Study Complete | Company Update | MS | 11001 | |
| 13 Mar 2026, 09:21 | BlinkLab Forms Partnership with SHANK2 Autism Foundation | Company Update | — | 11001 |
1–50 of 91
1 / 2